Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 13.29 M14.15 M13.61 M13.71 M13.49 M 54.97 M Research & development ————— — Operating income 38.99 M44.82 M48.15 M48.86 M48.81 M 190.64 M Non-Operating Income, Total 1.19 M2.61 M2.53 M2.49 M2.17 M 9.8 M Interest expense, net of interest capitalized 61.84 M62.79 M63.03 M61.66 M58.48 M 245.96 M Non-Operating Income, excl. Interest Expenses -60.65 M-60.18 M-60.5 M-59.17 M-56.31 M -236.16 M Unusual income/expense ————— — Pretax income 12.02 M16.5 M19.82 M19.65 M18.7 M 74.67 M Equity in earnings ————— — Taxes 3.12 M4.2 M4.96 M3.95 M5.6 M 18.7 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 8.9 M12.3 M14.87 M15.69 M13.1 M 55.97 M Discontinued operations ————— — Net income 8.9 M12.3 M14.87 M15.69 M13.1 M 55.97 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 8.9 M12.3 M14.87 M15.69 M13.1 M 55.97 M Basic earnings per share (Basic EPS) 0.090.120.150.150.13 0.55 Diluted earnings per share (Diluted EPS) 0.090.120.150.150.13 0.55 Average basic shares outstanding 101.82 M101.99 M102.03 M101.81 M101.27 M — Diluted shares outstanding 101.82 M101.99 M102.03 M101.81 M101.45 M — EBITDA -21.92 M-16.89 M-12.48 M-10.03 M-8.09 M -47.49 M EBIT -25.04 M-20.66 M-17.21 M-15.14 M-11.49 M -64.5 M Cost of revenue 2.98 M2.52 M2.4 M2.13 M1.01 M 8.06 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 3.12 M3.77 M4.73 M5.11 M3.4 M 17.01 M